MyProstateScore 2.0 (MPS2) is a urine test designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7) by analyzing a comprehensive array of 18 unique gene transcripts.
Come see us at the Western Section American Urological Association’s annual meeting October 1-5, 2023 and discover how a 30-second urine sample can give you personalized insights to guide your patients.
Join us for Breakfast and an Educational Discussion Session
Michael S. Cookson, M.D. will review the latest prostate cancer guidelines and biomarker tests during our special breakfast symposium.
Date: Thursday, October 5, 2023
Time: 8:00am PST
Location: Everline Resort, Grand Sierra Ballroom
This breakfast is free for all WSAUA attendees.